Skip to product information
RETATRUTIDE 40mg vial (Lyophilized peptide)
$119.00
Sale price
$119.00
Regular price
How It Works:
RETATRUTIDE acts as a "triple G" agonist, combining three distinct mechanisms:
RETATRUTIDE acts as a "triple G" agonist, combining three distinct mechanisms:
- GLP-1 (Glucagon-like peptide-1): Suppresses appetite and regulates blood sugar.
- GIP (Glucose-dependent insulinotropic polypeptide): Enhances fat metabolism and reduces nausea.
-
Glucagon: Increases energy expenditure, allowing the body to burn more calories.
Key Findings & Benefits
- High Efficacy: up to 24%–25% weight loss, which is higher than agents like semaglutide Ozempic and comparable to bariatric surgery.
- Fat Reduction: It promotes significant fat reduction and improvements in liver fat (steatosis).
-
Metabolic Improvement: It significantly lowers HbA1c levels and improves insulin sensitivity in type 2 diabetes patients.
Side Effects & Safety
The side effects are similar to other GLP-1 medications, primarily affecting the gastrointestinal system:
The side effects are similar to other GLP-1 medications, primarily affecting the gastrointestinal system:
- Common Adverse Events: Nausea, diarrhea, vomiting, and constipation.
-
Dose-Dependent Effects: Side effects are generally mild-to-moderate and tend to occur during dosage increases.
Administration & Availability
- Administration: It is designed as a once-weekly self-injection.
- This product is for Research purposes only not for Human use .